Research study of an investigational medication for Primary Insomnia

Study Description

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Outpatient Trial of XXXX in Adults with Primary Insomnia

Length of study: Up to 8 weeks

Number of office visits: 8 for most subjects

At no cost, qualified participants receive study medication and study related services. In addition there is compensation up to $600.00 for time and travel.

Study inclusion/exclusion criteria

This study is only available to persons who:

• Can fluently read and speak English.
• Are 18 to 64 years old.
• Are without serious health problems.
• Are not addicted to drugs or alcohol.
• Are not currently taking sedating medication or supplements.
   

[Home] [For Patients] [Studies] [FAQ] [Sponsor Overview] [Contact Us]